News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 08:35:00 05/07/2024 pm IST			5-day change	1st Jan Change
2,845 ^PTS	+0.24%		-1.49%	+24.57%

02/07	Indices: CAC relaxes, Merval soars
05/06	Nordic Shares Moved Upward Wednesday; Crayon Group Topped Leaders	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Danske Bank A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 DANSKE	03/05	CI
Danske Bank A/S Provides Earnings Guidance for the Year 2024 DANSKE	03/05	CI
Genmab Posts Q1 Net Profit Surge; Revenue Jumps GMAB	03/05	MT
Genmab A/S : Investor Presentation - May 2024 GMAB	03/05	PU
Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK NOVO B	03/05	MT
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity NOVO B	02/05	AQ
Genmab Reports Higher Interim Q1 Results; Maintains 2024 Guidance GMAB	02/05	MT
Novo Nordisk CEO: Demand for Wegovy outstrips supply NOVO B	02/05	MT
AP MOLLER-MAERSK : Low-end of the 2024 guidance revised upwards MAERSK B	02/05
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions NOVO B	02/05
Transcript : Genmab A/S, Q1 2024 Earnings Call, May 02, 2024 GMAB	02/05
Vegfinans Innlandet AS - Successful placement of new NOK bond issue DANSKE	02/05	AQ
GN STORE NORD : Solid profitability boosts investor sentiment GN	02/05
Genmab A/S : Interim Report for the First Quarter of 2024 GMAB	02/05	PU
Genmab A/S : First Quarter 2024 Financial Results Presentation GMAB	02/05	PU
Tranche Update on Genmab A/S's Equity Buyback Plan announced on March 1, 2021. GMAB	02/05	CI
Tranche Update on Genmab A/S's Equity Buyback Plan announced on March 25, 2024. GMAB	02/05	CI
Genmab A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 GMAB	02/05	CI
Genmab Announces Financial Results for the First Quarter of 2024 GMAB	02/05	GL
Moody's Raises Danske Bank’s Ratings; Outlook Changed to Stable DANSKE	02/05	MT
Orsted CEO: Supply Chain Across Offshore Industry Is Still Tight ORSTED	02/05	RE
Danske Bank A/S : Comment on statement on review of remuneration policy and remuneration practice 1 DANSKE	02/05	PU
Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat NOVO B	02/05	MT
Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 NOVO B	02/05	RE
NOVO NORDISK : Gets a Buy rating from Barclays NOVO B	02/05	ZD
Novo Nordisk Announces Wegovy (Semaglutide Injection) Available in Canada NOVO B	02/05	CI
Transcript : Ørsted A/S, Q1 2024 Earnings Call, May 02, 2024 ORSTED	02/05
Novo Nordisk A/S : Go to the Q1 2024 company announcement NOVO B	02/05	PU
AP Moller Maersk : Maersk Q1 2024 Results Press Release MAERSK B	02/05	PU
ISS A/S : 2024 Q1 Trading Update Report ISS	02/05	PU
ISS A/S : 2024 Q1 Trading Update Presentation ISS	02/05	PU
Novo Nordisk A/S : Open the Q1 2024 investor presentation NOVO B	02/05	PU
MOLLER-MAERSK : Goldman Sachs reiterates its Neutral rating MAERSK B	02/05	ZD
NOVO NORDISK : UBS gives a Neutral rating NOVO B	02/05	ZD
MOLLER-MAERSK : UBS keeps its Buy rating MAERSK B	02/05	ZD
MOLLER-MAERSK : Receives a Sell rating from Bernstein MAERSK B	02/05	ZD
Tranche Update on Novo Nordisk A/S (CPSE:NOVO B)'s Equity Buyback Plan announced on January 31, 2024. NOVO B	02/05	CI
Novo Nordisk A/S Revises Earnings Guidance for the Year 2024 NOVO B	02/05	CI
Novo Nordisk A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 NOVO B	02/05	CI
Novo Nordisk Q1 Earnings, Net Sales Climb NOVO B	02/05	MT